Literature DB >> 3651313

Fansidar hypersensitivity pneumonitis.

D McCormack1, W K Morgan.   

Abstract

We report a subject who had Fansidar prescribed to him for the purpose of malaria prophylaxis. This agent is a combination of pyrimethamine and sulphadoxine. He subsequently developed severe hypersensitivity pneumonia and required mechanical ventilation. We believe that sulphadoxine was responsible for his illness.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3651313     DOI： 10.1016/0007-0971(87)90140-9

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN： 0007-0971


  6 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Pulmonary toxicity of malaria prophylaxis.

Authors:  A C Davidson; C Bateman; C Shovlin; M Marrinan; G H Burton; I R Cameron
Journal:  BMJ       Date:  1988-11-12

Review 3.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 4.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).

Authors:  P T Daniel; J Holzschuh; P A Berg
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

Review 6.  Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.

Authors:  Philip J Peters; Michael C Thigpen; Monica E Parise; Robert D Newman
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.